12:00 AM
 | 
Apr 17, 2000
 |  BC Week In Review  |  Company News  |  Deals

BioQuest, Biovector deal

The companies will evaluate the development of an HIV vaccine that combines HIVX's cocktail of HIV...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >